Cerno Pharma Hit With Warning Letter Over Adulterated Products

Drug GMP Report
A A
The FDA slammed Cerno Pharmaceuticals for producing adulterated drugs at its Miami, Florida facility.

To View This Article:

Login

Subscribe To Drug GMP Report